Neuser D, Stasch J P, Morich F J
Bayer AG, Analytical Therapy Research, Department of Pharmacology, Wuppertal, F.R.G.
Eur J Pharmacol. 1988 Feb 9;146(2-3):341-4. doi: 10.1016/0014-2999(88)90313-5.
Atrial natriuretic peptide (ANP) III stimulated the formation of intracellular cGMP in renal epithelial cells (LLC-PK1) dose dependently. Incubation of LLC-PK1 cells with [Arg8]vasopressin resulted in an increase in intracellular cAMP levels. The stimulatory effect of ANP III on the cyclic cGMP system was inhibited by coincubation with [Arg8]vasopressin in a dose-dependent manner.